Ruiz-Lorente I, Gimeno L, Lopez-Abad A, Lopez Cubillana P, Fernandez Aparicio T, Asensio Egea LJ, Moreno Aviles J, Donate Iniguez G, Guzman Martinez-Valls PL, Server G, Ferri B, Campillo JA, Martinez-Sanchez MV, Minguela A. Differential Role of NKG2A/HLA-E Interaction in the Outcomes of Bladder Cancer Patients Treated with M. bovis BCG or Other Therapies. Biomedicines. 2025 Jan 10;13(1):156. doi: 10.3390/biomedicines13010156. PubMed PMID: 39857739; PubMed Central PMCID: PMC11760850.
AÑO: 2025; IF: 3.9
|
Rosino Sanchez A, Garcia Torralba E, Girela Baena E, Macias Cerrolaza JA, Tudela Pallares J, Zafra Poves M, Barcelo Bayonas I, Munoz Guillermo V, Fernandez Aparicio T. Early diagnosis of prostate cancer in healthy men with germline mutations in DNA Damage Response (DDR) pathways: A literature review and proposal for a screening strategy. Actas Urol Esp (Engl Ed). 2025 Apr;49(3):501686. doi: 10.1016/j.acuroe.2025.501686. Epub 2025 Feb 11. English, Spanish. PubMed PMID: 39947293.
AÑO: 2025
|
Ruiz-Lorente I, Gimeno L, Lopez-Abad A, Lopez Cubillana P, Fernandez Aparicio T, Asensio Egea LJ, Moreno Aviles J, Donate Iniguez G, Guzman Martinez-Valls PL, Server G, Escudero-Bregante JF, Ferri B, Campillo JA, Pons-Fuster E, Martinez Hernandez MD, Martinez-Sanchez MV, Ceballos D, Minguela A. Exploring the Immunoresponse in Bladder Cancer Immunotherapy. Cells. 2024 Nov 22;13(23):1937. doi: 10.3390/cells13231937. PubMed PMID: 39682686; PubMed Central PMCID: PMC11640729.
AÑO: 2024; IF: 5.1
|